Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Integra Therapeutics, a global leader in creating cutting-edge gene-writing tools to improve the efficacy, precision and ...

Although some biologists have since poured cold water on the actual science behind the dire wolf’s revival, there’s now talk ...

The kissing disease affects 90% of adults and could explain your fatigue and brain fog. Discover how Epstein-Barr virus might ...

The genomes of long-living, big-brained mammal species reveal that they carry more copies of immunity genes. Experts ...

Discover the seven primary causes of thyroid disorders affecting women, from autoimmune triggers and hormonal fluctuations to ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study ...

Mar. 12, 2025 — Lupus is an autoimmune disease where the ... Jan. 17, 2025 — Sunburn has traditionally been attributed to UV-induced DNA damage. However, a new study reveals that RNA, another ...

A gray wolf may have been spotted in Normandy for the first time in over 100 years, raising hopes for the species’ return to ...

While the general prevalence of systemic lupus erythematosus (SLE) in India is reported as 3.2 per 100,000 population, specific data on various types of lupus within India are limited.

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.